LRRK2 Parkinson disease mutations enhance its microtubule association

Lauren R Kett1, Daniela Boassa, Cherry Cheng-Ying Ho

  • 1Department of Neurology, University of Michigan Medical School, Ann Arbor, MI, USA.

Human Molecular Genetics
|November 15, 2011
PubMed

Insights

Mutations in leucine-rich repeat kinase 2 (LRRK2) cause Parkinson disease (PD) by forming abnormal filaments that bind to microtubules. This discovery offers new insights into PD pathogenesis and potential therapeutic targets.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Dominant mutations in leucine-rich repeat kinase 2 (LRRK2) are the primary genetic cause of Parkinson disease (PD).
  • LRRK2 variants are also identified as risk factors for sporadic PD through genome-wide association studies.
  • The precise mechanisms by which LRRK2 contributes to neurodegeneration are not fully understood, although kinase function is implicated.

Purpose of the Study:

  • To investigate the cellular and structural consequences of LRRK2 mutations associated with Parkinson disease.
  • To elucidate the role of LRRK2 oligomerization and its interaction with cellular components in PD pathogenesis.

Main Methods:

  • Utilized cell line transfections and primary neuronal cultures to study LRRK2 mutant behavior.
  • Employed advanced ultrastructural analyses, including immuno-electron microscopy and electron microscopic tomography.
  • Assessed the requirement of kinase function and specific protein domains (WD40) for observed LRRK2 effects.

Main Results:

  • Most LRRK2 Parkinson disease mutants exhibit enhanced oligomerization, forming filamentous structures.
  • These LRRK2 filaments are recruited onto the cellular microtubule network in an ordered, periodic manner.
  • Microtubule association of LRRK2 filaments necessitates intact kinase activity and the WD40 domain.

Conclusions:

  • LRRK2 mutations induce abnormal filament formation and microtubule association, representing a novel pathogenic mechanism in Parkinson disease.
  • Microtubules may play a significant role in the neurodegenerative processes associated with LRRK2 mutations.
  • Findings suggest potential therapeutic strategies targeting LRRK2-microtubule interactions in PD.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Microtubule Associated Motor Proteins01:32

Microtubule Associated Motor Proteins

Eukaryotic cells have different motor proteins for transporting various cargo within the cell. These motor proteins differ based on the filament they associate with, the direction they move within the cell, and the type of cargo they transport. Motor proteins that associate with microtubules are known as microtubule-associated motor proteins. There are two families of microtubule-associated motor proteins —Kinesins and Dyneins. Both these proteins assist in the transport of cellular cargos...